Trial Questions Role of Dual Immunotherapy in First-Line NSCLC

Published Date: 26 Aug 2024

In Japanese trial, nivolumab-ipilimumab didn't improve OS versus pembrolizumab, had more toxicity

Read Full News

Latest News

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines

A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. The study introduces an immune cell homing hydrogel-based platform designed ...

A radiotheranostic approach designed to combat aggressive cancers

UCLA scientists, together with a team of international collaborators, have identified a promising new treatment strategy that can detect, kill and reprogram aggressive, treatment-resistant tumors like osteosarcomas and glioblastoma.

Exercise may help breast cancer survivors manage weight

New UBC Okanagan research shows that exercise can do more than improve the strength and cardiovascular endurance of women who have survived breast cancer.

Lesser-known lobular breast cancer on the rise in U.S. women

The American Cancer Society has released a report on occurrence and outcomes in the United States for this subtype of breast cancer. Findings show an estimated 33,600 women will be diagnosed with lobular breast cancer or ...

Study recommends new grading system for invasive squamous cell carcinoma of the lung

Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, targetable molecular ...

Neural networks and label-free microscopy enable accurate detection of pancreatic tumors

Pancreatic neuroendocrine neoplasms (PNENs) are a rare form of cancer that affects hormone-producing cells in the pancreas. Although uncommon, their incidence has been rising steadily over the past few decades.

Todays Updates

Nuclear missile workers are contracting cancer: They blame the bases

At a memorial service in 2022, veteran Air Force Capt. Monte Watts bumped into a fellow former Minuteman III nuclear missile operator, who told him that she had non-Hodgkin lymphoma.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice. Not only did up to ...

Todays Updates

Nuclear missile workers are contracting cancer: They blame the bases

At a memorial service in 2022, veteran Air Force Capt. Monte Watts bumped into a fellow former Minuteman III nuclear missile operator, who told him that she had non-Hodgkin lymphoma.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice. Not only did up to ...

Latest News

A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. The study introduces an immune cell homing hydrogel-based platform designed ...

UCLA scientists, together with a team of international collaborators, have identified a promising new treatment strategy that can detect, kill and reprogram aggressive, treatment-resistant tumors like osteosarcomas and glioblastoma.

New UBC Okanagan research shows that exercise can do more than improve the strength and cardiovascular endurance of women who have survived breast cancer.

The American Cancer Society has released a report on occurrence and outcomes in the United States for this subtype of breast cancer. Findings show an estimated 33,600 women will be diagnosed with lobular breast cancer or ...

Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, targetable molecular ...

Pancreatic neuroendocrine neoplasms (PNENs) are a rare form of cancer that affects hormone-producing cells in the pancreas. Although uncommon, their incidence has been rising steadily over the past few decades.

News All Time

New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers

A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative breast and urothelial bladder cancers within four hours, according to research published in the Journal of Nuclear Medicine. ...

Distribution of fat could influence cancer risk, study suggests

How fat is distributed in people's bodies could make a difference to their risk of certain cancers, according to new research led by the University of Bristol. The study is published in JNCI: Journal of the National Cancer ...

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

WHO has released a new landscape analysis that exposes critical gaps in global research and development (R&D) efforts related to cancer. The report reveals that despite rapid advancements in clinical research, investment ...

Health researchers discuss Medicaid cancer screening trends, best practices

New Jersey has the 10th-highest rate of cancer incidence in the United States. It is the second leading cause of death in New Jersey, and thousands of residents die from preventable cancers each year.

Obesity-associated cancers may be on the rise in Puerto Rico

The incidence of obesity-associated cancers in Puerto Rico rose significantly between 2000 and 2022, according to research presented at the 18th AACR Conference on the Science of Cancer Health Disparities, held September ...

Scientists identify dual protein targets to weaken pancreatic cancer defenses

Indiana University School of Medicine scientists have identified a new way to weaken pancreatic cancer's defenses by targeting two key proteins that help the deadly disease resist treatment. The study, recently published ...

Study finds 10% of pediatric blood cancers may stem from medical imaging radiation

A study led by UC San Francisco and UC Davis has concluded that radiation from medical imaging is associated with a higher risk of blood cancers in children.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

A new study, led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, captured details of glioblastoma that had never before been seen and revealed a surprise ...

Algorithm that predicts pancreatic cancer metastasis could help avoid unnecessary surgeries

Pancreatic cancer remains one of the biggest challenges in the field of oncology. Numbers of cases are increasing, and the latest personalized therapies and immunotherapy are not yet yielding results. Much of the effort is ...

Basal stem-like cells identified as origin of small cell lung cancer in lab models

A new study reveals that small cell lung cancer (SCLC) likely begins in basal stem-like cells rather than in neuroendocrine cells, marking a major shift in the understanding of this aggressive disease that is often associated ...

Remote monitoring can improve recovery from cancer surgery

A new study co-authored by Tracy Crane, Ph.D., RDN, co-leader of the Cancer Control Program at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, shows that remote perioperative ...

Targeted radiation therapy shows near-complete response in rare sarcoma patients

A novel targeted radiation approach for a rare form of malignant tumor—the solitary fibrous tumor (SFT)—has shown significant success, achieving a near-complete response in three patients. The therapy significantly reduced ...

As pesticides and wildfires rise, kids with cancer need resources

A growing body of research ties environmental pollutants to worse health and shorter life spans for childhood cancer survivors. Yet medical providers lack sufficient resources to address these risks with patients, a recent ...

Two-part prodrug system activates immune attack only in tumor's unique environment

Scientists have developed a smarter way to activate the immune system against cancer, potentially making treatments safer and more precise.

Study finds primary-care doctors often overlook prostate cancer risk in Black men

Although Black men die of prostate cancer at twice the rate of the rest of U.S. males, this fact often is not known or considered during appointments with their primary-care clinicians to discuss a common screening test.

Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals

Researchers from Keele University have revealed that retired Olympic athletes are more likely to develop skin cancer and osteoarthritis than the general population.

Recommended News For You

Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma

The Benefits of Exercise for Substance Use Disorders.

Enhanced CAR T cell therapy offers new strategy for lymphoma

Non-Hodgkin lymphomas that are indolent have been linked to psychological distress.

Optimizing Sequencing of BCMA-Directed Therapies in Myeloma

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

Francis Collins reveals that he was diagnosed with "aggressive" prostate cancer.

Recommended Articles For You

Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling 

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma 

The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025 

Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Many Americans unaware of links between HPV and cancers, poll reveals

2.

'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning

3.

Modified personalized cancer vaccine generates powerful immune response

4.

'Ray of hope': New developments in the fight against various cancers.

5.

Does diabetes impact the prognosis of people with colorectal cancer?

1.

Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications

2.

Nuclear Medicine's Role in Battling Women's Cancers

3.

What Is Carboxyhemoglobin And How Can It Affect Your Health?

4.

Uncovering the Reality of Colon Cancer: A Look at Real Images

5.

Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

3.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

4.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot